TARA WEBB: Open Payments
NPI 1821390246 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,881 in 131 payments from 35 companies in 2025. Trend: 2023 $2,649 · 2024 $2,091 · 2025 $2,881
Food & beverage: $2,693Education: $188
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $305 |
| Merck Sharp & Dohme LLC | 11 | $276 |
| GlaxoSmithKline, LLC. | 15 | $247 |
| Eisai Inc. | 7 | $209 |
| Incyte Corporation | 5 | $166 |
| Genentech USA, Inc. | 7 | $140 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| Exelixis Inc. | 2 | $113 |
| Celgene Corporation | 4 | $102 |
| Agios Pharmaceuticals, Inc. | 3 | $90 |
Products named: KEYTRUDA, Lenvima, OJJAARA, KISQALI, OPDIVO, Polivy, PYRUKYND, IMKELDI.
Industry payments across MI — which companies pay providers there.
